Tag Archives: Asgeir Lande

Research: Genetic association study in ME/CFS

Posted on 03/30/2022 by wames

Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci, by Riad Hajdarevic, Asgeir Lande, Jesper Mehlsen, Anne Rydland, Daisy D Sosa, Elin B  Strand, Olav Mella, Flemming Pociot, Øystein Fluge, Benedict A Lie, Marte K … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Research: Genetic association study in ME/CFS

Genetic research: Fine mapping of the major histocompatibility complex (MHC) in ME/CFS

Posted on 09/13/2021 by wames

Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci, by Riad Hajdarevic, Asgeir Lande, Ingrid Rekeland, Anne Rydland, Elin B Strand, Daisy D Sosa, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Genetic research: Fine mapping of the major histocompatibility complex (MHC) in ME/CFS

Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Posted on 05/04/2020 by wames

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study